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MORBIDITY AND MORTALITY AFTER MAJOR
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WITH HEPATOCELLULAR CARCINOMA
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YU-CHUNG CHANG and TERUHISA NAKAMURA
Department ofSurgery, Hiroshima Red Cross Hospital, Hiroshima 730, and the
Second Department ofSurgery, Shimane Medical University, Izumo 693, Japan
Major hepatic resection was carried out on 23 adult patients with hepatocellular carcinoma (HCC) and
underlying cirrhosis of the liver (macronodular in six cases, micronodular in 11, and mixed type cirrhosis
in six). Pre-operative liver functional state was Child’s class A in 19, class B in three, and class C in one.
The operations performed were extended right lobectomy in four patients, right lobectomy in 10, left
lobectomy in one, and left lateral segmentectomy in eight. Fifteen postoperative complications were
found in 10 patients, five ofwhom had duplicated complications and finally died of liver failure 15-65 days
after operation. In three of those five patients, other complications (hemorrhagic shock in two and portal
thrombosis in one) had preceded liver failure. Eighteen patients tolerated the resection and were
discharged from hospital. However, among 13 noncirrhotic patients with HCCwho had undergone major
hepatic resection during the same period of time, only two had postoperative complications and all
patients were discharged from hospital. The 1-, 2- and 3-year survival rates in the 23 cirrhotics were
60.9%, 37.5% and 24.9% respectively, whereas the 1-5-year survival rates were all 61.5% in the 13
noncirrhotics. Thus, major hepatic resection may be indicated in selected patients with HCC and
associated cirrhosis, but meticulous managements during and after operation are mandatory to prevent
fatal postoperative liver failure.
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INTRODUCTION
More than 80% of Japanese patients with hepatocellular carcinoma (HCC) have
underlying cirrhosis of the liver1. Due to marked advances in diagnostic methods and
careful screening of risky patients, the resectability of HCC has increased in recent
years as relatively small HCCs are discovered more frequently2-4. Nevertheless,
there are many patients with cirrhosis and large HCCs that can be removed only by
major hepatic resection.
In Western countries, most surgeons are reluctant to perform major hepatic
resection in the presence of liver cirrhosis because of the high incidence of
postoperative liver failure5-7. As we have recently clarified, however, such an
attitude is not always valid, since the grade of liver cirrhosis varies from patient to
patient. It is apparently a fact that some selected patients with cirrhosis tolerate
extensive liver resection and have regeneration of the residual liver8.
Our criteria in the performance of major resection in those with cirrhosis have
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been that the candidates should have nearly normal pre-operative liver functions and
an acceptable amount of the remaining liver3’4. This study reports the results of
major hepatic resection performed along this line.
SUBJECTS AND METHODS
From January 1980 to March 1986, 204 patients with primaryHCC were admitted to
our surgical clinic. Hepatic resection was carried out on 134 patients with the
resectability of 65.7%. Thirty-six patients underwent major hepatic resection.
Twenty-three patients had associated cirrhosis of the liver, whereas 13 patients did
not. The pre-operative clinical background of these patients is summarized in Table
1. Age distributions are shown in Figure 1. The number of males and incidences of
alcohol abuse were significantly higher in the cirrhotic patients than in the
noncirrhotics (p<0.05). Pre-operative liver functions and Child’s classification are
shown in Table 2. All the data levels were worse in the cirrhotic patients than in the
noncirrhotic patients, but this was not statistically significant. In Table 3 are
summarized the pre-operative blood and coagulation studies. There were no
differences between the two groups.
Pre-operative complications
Among the 23 cirrhotic patients, the following complications were observed"
diabetes mellitus (3), cholelithiasis (1), small esophageal varices (1) and obstructive
Table 1 Pre-operative clinical data of 36 patients with HCC undergoing major hepatic resection.
Data Cirrhotics Noncirrhotics
(n=23) (n=13)
M/F 22/1 9/4
Age (yrs)
Mean + s.d. 56.9 + 12.1
Range 34-74
55.8 + 16.4
17-74
Duration of liver disease (yrs)
Less than 10 10 2
10-20 6 4
More than 20 4 0
Unknown 3 7
Alchohol abuse
Yes 9
No 14
2
11
Hepatitis B virus
Positive HBs-Ag 8/23 2/13
Positive anti-HBs 6/23 5/13
Positive anti-HBc 13/21 5/11
Those who consume alchohol of more than 50 g/day for longer than 5 years.
Measured by radioimmunoassay methods.MORBIDITY AND MORTALITY 47
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Figure Age distribution in 23 patients with and 13 patients without underlying cirrhosis of the liver who
underwent major hepatic resection in the treatment of hepatocellular carcinoma.
Table 2 Pre-operative liver tests and Child’s classification in 36 patients with HCC.
Data Cirrhotics (n=23) Noncirrhotics (n=13)
Mean +_ s.d. Range Mean +_ s.d. Range
AST (IU/1) 86 + 46
ALT (IU/1) 74 43
Total bilirubin (mg/100ml) 1.3 + 1.5
Albumin (g/100ml) 3.9 _+ 0.4
T. cholesterol (mg/100ml) 160 + 34
BSP (30’)c (%) 22.0+ 10.6
ICG (15’) (%) 14.5 + 6.2
Child’s class
A 19
B 3
C
27-216 79 + 50 21-167
10-188 44 _+ 29 13-117
0.6-8.2 0.7 _+. 0.1 0.6 + 0.9
2.8-4.7 4.1 + 0.4 3.5-4.9
118-250 179 + 44 132-291
6.0-44.0 15.7 + 9.9 4.5-38.0
4.0-28.8 10.8 + 5.0 4.0-18.3
13
0
0
Aspartate aminotransferase (normal, 0-37).
Alanine aminotransferase (normal, 3-32).
Bromosulphalein retention rate at 30 min (normal, 0-10).
Indocyanine green retention rate at 15 min (normal, 0-10).48 N. NAGASUE, H. YUKAYA, H. KOHNO, Y. CHUNG CHANG and T. NAKAMURA
Table 3 Pre-operative hemogram and coagulation study in 36 patients with HCC.
Data Cirrhotics (n=23) Ndncirrhotics (n=13)
Mean +_ s.d. Range Mean + s.d. Range
WBC(/mm3) 5604 + 1318 3500-7900
RBC (x 104/mm3) 433 + 57 287-508
Hb (g/100ml) 13.6 + 1.7 9.9-15.7
Platelet (x 104/mm3) 16.3 + 6.3 8.1-34.0
Prothrombin time (%) 97 + 17 65-140
APTT (sec.) 32.4 + 4.3 25.4-43.4
Normotest (%) 83 + 21 61-128
Fibrinogen (mg/100ml) 245 + 80 125-430
6138 + 1775 2700-8900
414 +__ 58 340-525
12.9 + 1.7 10.3-15.2
23.9 + 7.9 13.4-40.2
105 +__ 7 98-117
32.2 + 3.3 25.7-36.8
93 + 27 54-140
299 + 85 185-500
Activated partial thromboplastin test.
jaundice due to tumor growth in the common bile duct (1). One patient had
undergone esophageal transection in the treatment of bleeding esophageal varices
2.5 years previously. Three of the 13 noncirrhotic patients had associated conditions:
atelectasis of the right lower lobe of the lung, cholelithiasis, and open gastric ulcer,
respectively.
Operative Methods
In all patients undergoing lobectomy or extended lobectomy, the inflow vessels and
hepatic duct of the lobe to be removed were ligated and divided first. In right
lobectomy and extended right lobectomy, the right hepatic vein was divided before
resection. The left hepatic artery was ligated before left lateral segmentectomy, but
the left portal and hepatic veins were divided while the liver parenchyma was
dissected. Parenchymal dissection was performed along the demarcation line with
the use of the finger fracture method. When the Lin’s liver clamp could be used, it
was applied to the liver to remain just beside the demarcation line. The clamp was
utilized in eight patients with and eight patients without cirrhosis. Right thoracotomy
was added due to a huge liver in three patients without cirrhosis. Biliary
reconstruction was carried out in a cirrhotic patient with tumor growth in the
common bile duct in addition to right lobectomy.
Statistical Methods
Statistical analysis were carried out according to the chi-square test and unpaired
Student t-test. All the data are presented as mean + s.d. A P value less than 0.05 was
considered as being statistically significant. The survival rate was obtained by the
Kaplan-Meier method.
RESULTS
Blood Loss and Operation Time
In the cirrhotic patients, blood loss during surgery ranged from 100 to 5500 g with anMORBIDITY AND MORTALITY 49
average of 2150 + 1554, which did not differ from that in the noncirrhotic patients
(1775 + 1765 g). The mean operation time was 175 + 76 min (range, 60-370) in the
cirrhotic and 213 + 90 min (range, 64-400) in the noncirrhotic group. There was no
difference between the two groups.
Intraoperative Complications
Right pneumothorax occurred due to a diaphragmatic injury in two patients with
cirrhosis. The common bile duct was erroneously transected in a noncirrhotic patient
with a huge tumor.
Postoperative Morbidity and Morality
Ten patients with cirrhosis had 15 postoperative complications (Table 4). Five
patients with liver failure subsequently died in coma 15-65 days after operation. In
three of them, other complications had preceded hepatic failure. Two patients had
hemorrhagic shock and were re-operated. In the third patient, liver failure was
accounted for by preceding portal thrombosis, which was verified at autopsy. Thus,
only two patients developed postresectional liver failure with no other predisposing
causes than major hepatectomy (Table 5). On the other hand, only two of the
noncirrhotic patients had postoperative complications, both nonfatal: acute gastric
bleeding in one and intestinal fistula in the other (Table 6). However, the differences
in complication and mortality rates were not statistically significant between the two
patient groups (0.05<p<0.1).
Table 4 Post-operative complications in 23 cirrhotic patients.
Complications No. ofpatients
Liver failure 5
Rebleeding 4
Upper GI bleeding 2
Biliary fistula 2
Acute pancreatitis
Portal thrombosis
Total 15
GI=gastrointestinal.
Complications were duplicated in five patients
Histopathologic Study
Liver cirrhosis was of macronodular type in six patients, micronodular in 11, and
mixed type in six. All of the patients without cirrhosis had chronic hepatitis
histologically, active in three instances and inactive in 10. Autopsy was done in three
of five patients who died of liver failure. The residual liver weight was 955 g (MK),
1070 g (IN), and 760 g (MY), respectively. Postmortem needle biopsy of the liver was
carried out in one patient (GH). Histologically, patchy necrosis of the residual liver
was found in two patients in whom hemorrhagic shock had preceded the liver failureoMORBIDITY AND MORTALITY 51
(Figure 2). In a patient with portal thrombosis, diffuse fat infiltration was observed in
the liver remnant. However, liver cells were relatively well preserved but
intercellular edema and leucocyte infiltration were noted in the liver of a patient
(MK) who died of only postresectional liver failure (Figure 3). Bile stasis in small
intrahepatic bile ducts was uniformly found in these four specimens.
Late Survival
Among the 23 patients with cirrhosis, 18 patients were discharged from hospital.
However, 12 patients died after 3-45 months (average 17.5 + 12.7), 10 due to cancer
recurrence and two due to hepatic failure. Only six patients are alive at present. On
the other hand, all the noncirrhotic patients were discharged from hospital. Five of
them died oftumor recurrence 5-9 months (average 6.9 + 1.8) after operation. Eight
patients are alive at the time this article is being prepared. In Figure 4 are shown the
cumulative survival rates of both groups. The 1-, 2- and 3-year survivval rates in the
23 patients with cirrhosis were 60.9%, 37.5% and 24.9%, respectively. The 1-5-year
survival rates were 61.5% in all the 13 patients without cirrhosis. The survival rates
after 2.6 years were significantly different between the two patient groups (p<0.05).
DISCUSSION
The liver has a remarkable regenerative capacity after major resection, provided it is
normal. It is known that a liver tolerates a 70-80% resection safely9’1. Several
authors11’12 have reported a formidable resection as large.as 90% with subsequent
regeneration of the liver remnant. On the other hand, it has been assumed that
cirrhotic livers are less able to regenerate and accordingly major resection is
contraindicated in the presence of liver cirrhosis5-7 We have recently shown,
however, that some selected patients with cirrhosis can tolerate major resection3’4
and that regenaration of the residual liver takes place, although more slowly than
with the normal liver8.
In the current investigation, we have reviewed 23 cirrhotic and 13 noncirrhotic
patients with HCC who had undergone major hepatic resection. When we selected
the cirrhotic patients for major hepatectomy, there was no definite criteria except for
almost normal pre-operative liver function and sufficient remaining liver volume.
There was no significant difference in pre-operative liver tests between the cirrhotic
and noncirrhotic patients. The only difference was the presence or absence of
underlying cirrhosis. Fifteen major complications occurred in 10 cirrhotic patients,
five of whom had duplicated complications and died of hepatic failure 15-65 days
after operation. Therefore, the hospital death rate was 21.7%. This rate was in
remarkable contrast to the absence of mortality in the 13 noncirrhotic patients. This
mortality rate was also higher than that after major resection of noncirrhotic livers
with HCC reported in the world literature13-16. Among the cirrhotic patients, no
definitive differences were found in pre-operative liver tests or operative methods
between the patients who survived and those who died.
The most awful and fatal complication after major resection of the cirrhotic livers
is postoperative liver failure. Once it occurs, the chance for the patient to survive is
extremely low. Actually, the cause of death was liver failure in all five patients who
died in the present series. However, three ofthem had had complications before liver52 N. NAGASUE, H. YUKAYA, H. KOHNO, Y. CHUNGCHANG and T. NAKAMURA
Figure 2 Histologic sections in a patient (GH) who died of liver failure occuring subsequently to
hemorrhagic shock. Upper: cirrhotic portion of the resected specimen( 4, H&E). Lower" postmortem
needle biopsy of the residual liver. Note patchy necrosis of the liver( 10, H&E).MORBIDITY AND MORTALITY 53
Figure 3 Histologic sections in a patient (MK) who died of liver failure without preceding complications.
Upper: cirrhotic portion of the resected liver (x 4, H&E). Lower: residual liver at autopsy. Liver cells
were well preserved. Note inter-cellular edema and bile statis in small bile ducts (x 10, H&E).54 N. NAGASUE, H. YUKAYA, H. KOHNO, Y. CHUNG CHANG and T. NAKAMURA
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Figure 4 Cumulative survival curves in 23 patients with and 13 patients without liver cirrhosis after major
hepatic resection. The survival rates after 2.6 years were significantly different between the two groups.
failure developed; i.e. liver resection itselfwas a sole cause of liver failure in only two
patients. In two patients who had had hemorrhagic shock before liver failure
occured, patchy necrosis of the residual liver found at postmortem examinations.
THus, careful operation and postoperative management can possibly reduce the
operative mortality.
In performing major hepatic resection in patients with cirrhosis, there are two
important points. One is the morphological and functional extent of the cirrhosis
with which the patient has to tolerate major hepatectomy. The other is the safe
extent of resection in each individual. We have tried to establish this in the present
study but could not reach any firm conclusion. Both questions are difficult to answer
at present because of the paucity of such experiences by other investigators and
ourselves. In 1973, Lin et al. 6 proposed the following criteria" hepatic lobectomy is
indicated for either right or left lobe if the cancer free lobe is macroscopically normal
or only very mildly cirrhotic; in the presence of moderately advanced cirrhosis,
hepatic lobectomy of the left lobe but not the right lobe can be performed without
much danger; in the case of advanced cirrhosis hepatic lobectomy for either lobe is
absolutely contraindicated. We agree with and follow their proposal but we have
been extending the indication of major resection in cases of moderately advanced
cirrhosis.MORBIDITY AND MORTALITY 55
The long-term survival of our patients with cirrhosis was not necessarily
satisfactory but we intend to continue our present treatment plan because hepatic
resection is the only permanent cure ofHCC in Japan, where liver transplantation is
not feasible as yet.
In the light of the current study, major hepatic resection may be indicated in
selected patients with HCC and associated cirrhosis, although postoperative
morbidity and morality are substantially higher than otherwise. Postoperative
complications, especially hemorrhagic shock, which may cause ischemia of the
residual liver, should be avoided in order to prevent fatal postresectional liver
failure.
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INVITED COMMENTARY
There is little question that performing a major heaptic resection in the face of
cirrhosis is fraught with increased mortality and morbidity. It remains difficult for us
to extrapolate from the Japanese experience to the American experience to the
Western experience, since patients certainly seem to react differently. Kinami and
associates (World J. Surg, 111,294-301, April 1986) reported a large series of patients
with hepatocellular carcinoma associated with liver cirrhosis undergoing hepatic
resection, and indicated that hepatic resection was effective in the treatment of
patients with lesions less than 5 cm in diameter. It is ususual for surgeons in Western
countries to deal with such small lesions, however.
Bismuth and associates (World J. Surg., 1t1, 311-317, April 1986) reported a
Western experience of resection on cirrhotic patients. There were no five-year
survivors and they pointed out that the recently reported favourable long-term
results were patients with small hepatocellular carinomas in Eastern countries, and
were not matched by their studies.
As intra-operative ultrasonography becomes more refined it may be possible to
expand our vistas and perform small isolated resections along non-anatomic planes
of smaller lesions. I still feel, however, that one should have reservations about
performing a major resection in the face of cirrhosis.
Seymour I. Schwartz
University of Rochester
New York, USA